155 results on '"Uchiyama, Michihiro"'
Search Results
2. Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis
3. EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress
4. Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis
5. Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
6. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
7. Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan
8. Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients
9. MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
10. POSTER: MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
11. S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
12. Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study
13. Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
14. Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study
15. Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study
16. Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study
17. P-198: Isatuximab plus Carfilzomib and Dexamethasone in East Asian patients with relapsed Multiple Myeloma: IKEMA subgroup analysis
18. Primary ovarian non-Hodgkinʼs lymphoma
19. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
20. Isatuximab plus carfilzomib and dexamethasone in east Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.
21. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
22. Unrelated Cord Blood Transplantation after Myeloablative Conditioning for Adult Patients with Refractory Anemia
23. Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study
24. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
25. Pulmonary alveolar proteinosis in a patient with Behcetʼs disease
26. Consensus JH Gene Probes with Conjugated 3′-Minor Groove Binder for Monitoring Minimal Residual Disease in Acute Lymphoblastic Leukemia
27. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation
28. Short consensus probes with 3′-minor groove binder of the immunoglobulin heavy-chain gene for real-time quantitative PCR in B-cell non-Hodgkin lymphomas
29. Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years
30. Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative–polymerase chain reaction
31. The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group
32. Safety of Crovalimab Versus Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Pooled Results from the Phase III COMMODORE 1, COMMODORE 2, and COMMODORE 3 Studies
33. Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
34. Case report of subcutaneous panniculitis-like T-cell lymphoma complicated by eyelid swelling
35. Case report of subcutaneous panniculitis-like T-cell lymphoma complicated by eyelid swelling.
36. Diffuse Large B-cell Lymphoma Complicated with Autoimmune Thrombocytopenia
37. Low-dose acyclovir against reactivation of varicella zoster virus after unrelated cord blood transplantation
38. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma
39. Unusual presentation of serum markers for suspected Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma
40. Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia
41. Thyroid Involvement in Pulmonary Langerhans Cell Histiocytosis
42. Acute Idiopathic Thrombocytopenic Purpura Complicated with Diffuse Alveolar Hemorrhage in an Elderly Patient
43. Pulmonary Involvement in Systemic Hodgkin's Disease
44. Idiopathic thrombocytopenic purpura associated with Helicobacter pylori infection in a patient with liver cirrhosis accompanying hepatitis B
45. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
46. Human Herpesvirus 6 Variant B Infection in Adult Patients after Unrelated Cord Blood Transplantation
47. Impact of Acute GVHD on Immune Reconstitution after Cord Blood Transplantation in Adult.
48. Contribution of T-Cell Reconstitution during the Early Phase after Cord Blood Transplantation to Favorable Clinical Outcomes.
49. Development of consensus fluorogenically labeled probes of the immunoglobulin heavy‐chain gene for detecting minimal residual disease in B‐cell non‐Hodgkin lymphomas
50. Invasive pulmonary aspergillosis diagnosed by broncho-alveolar lavage.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.